Qualitest Launches Generic Singulair

Qualitest Pharmaceuticals today confirmed that it has launched a generic version of Singulair (montelukast sodium) Tablets and Chewable Tablets, following the expiration of the last patent that provides Merck U.S. market exclusivity.  Qualitest will begin shipping the product immediately.   Montelukast Sodium Tablets are labeled for use in treating symptoms of asthma and allergic rhinitis.